Market Currents
ISIS Pharmaceuticals (ISIS -1.8%) and Genzyme (SNY) say the Committee for Medicinal Products for...
-
Friday, December 14, 2012, 9:56 AM ETISIS Pharmaceuticals (ISIS -1.8%) and Genzyme (SNY) say the Committee for Medicinal Products for Human Use adopted a negative opinion for its marketing authorization of the cholesterol drug Kynamro, a setback for the treatment.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
